| CST4 |
CST4: Cystatin-S precursor |
CAPN3 |
CAPN3, CANP3, CANPL3, NCL1: Calpain-3 |
0.468 |
Evidence |
|
| CST4 |
CST4: Cystatin-S precursor |
CAPN2 |
CAPN2, CANPL2: Calpain-2 catalytic subunit precursor |
0.468 |
Evidence |
|
| CST4 |
CST4: Cystatin-S precursor |
MGMT |
MGMT: Methylated-DNA--protein-cysteine methyltransferase |
0.468 |
Evidence |
|
| CST4 |
CST4: Cystatin-S precursor |
CTSB |
CTSB, CPSB: Cathepsin B precursor |
0.468 |
Evidence |
|
| CST4 |
CST4: Cystatin-S precursor |
CTSL |
CTSL: Cathepsin L precursor |
0.468 |
Evidence |
|
| CST3 |
CST3: Cystatin-C precursor |
CAPN3 |
CAPN3, CANP3, CANPL3, NCL1: Calpain-3 |
0.468 |
Evidence |
|
| EGFR |
EGFR, ERBB1: Epidermal growth factor receptor precursor |
CBLC |
CBLC, CBL3, RNF57: Signal transduction protein CBL-C |
0.468 |
Evidence |
|
| EGFR |
EGFR, ERBB1: Epidermal growth factor receptor precursor |
STAT4 |
STAT4: Signal transducer and activator of transcription 4 |
0.468 |
Evidence |
|
| EGFR |
EGFR, ERBB1: Epidermal growth factor receptor precursor |
STAT2 |
STAT2: Signal transducer and activator of transcription 2 |
0.468 |
Evidence |
|
| ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
EPHA5 |
EPHA5, EHK1, HEK7: Ephrin type-A receptor 5 precursor |
0.468 |
Evidence |
|
| EDD1 |
EDD1, EDD, HYD, KIAA0896: E3 ubiquitin-protein ligase EDD1 |
ATXN2L |
ATXN2L, A2D, A2LG, A2LP, A2RP: Ataxin-2-like protein |
0.468 |
Evidence |
|
| VAMP4 |
VAMP4: Vesicle-associated membrane protein 4 |
ABI1 |
ABI1, SSH3BP1: Abl interactor 1 |
0.468 |
Evidence |
|
| DNAJC13 |
DNAJC13, KIAA0678, RME8: DnaJ homolog subfamily C member 13 |
PDK1 |
PDK1: [Pyruvate dehydrogenase [lipoamide]] kinase isozyme 1, mitochondrial precu |
0.468 |
Evidence |
|
| CTSL2 |
CTSL2, CATL2, UNQ268/PRO305, CTSU, CTSV: Cathepsin L2 precursor |
CST4 |
CST4: Cystatin-S precursor |
0.468 |
Evidence |
|
| KCNQ2 |
KCNQ2: Potassium voltage-gated channel subfamily KQT member 2 |
TRPV4 |
TRPV4, VRL2, VROAC: Transient receptor potential cation channel subfamily V memb |
0.468 |
Evidence |
|
| UTX |
UTX: Ubiquitously transcribed X chromosome tetratricopeptide repeat protein |
BGLAP |
BGLAP: Osteocalcin precursor |
0.468 |
Evidence |
|
| CXCL11 |
CXCL11, ITAC, SCYB11, SCYB9B: Small-inducible cytokine B11 precursor |
OPRM1 |
OPRM1, MOR1: Mu-type opioid receptor |
0.468 |
Evidence |
|
| CXCL11 |
CXCL11, ITAC, SCYB11, SCYB9B: Small-inducible cytokine B11 precursor |
DPP8 |
DPP8, DPRP1, MSTP097, MSTP135, MSTP141: Dipeptidyl peptidase 8 |
0.468 |
Evidence |
|
| SOCS3 |
SOCS3, CIS3, SSI3: Suppressor of cytokine signaling 3 |
EPHA5 |
EPHA5, EHK1, HEK7: Ephrin type-A receptor 5 precursor |
0.468 |
Evidence |
|
| CCL22 |
CCL22, A-152E5.1, MDC, SCYA22: Small-inducible cytokine A22 precursor |
OPRM1 |
OPRM1, MOR1: Mu-type opioid receptor |
0.468 |
Evidence |
|
| CCL22 |
CCL22, A-152E5.1, MDC, SCYA22: Small-inducible cytokine A22 precursor |
DPP8 |
DPP8, DPRP1, MSTP097, MSTP135, MSTP141: Dipeptidyl peptidase 8 |
0.468 |
Evidence |
|
| CCL21 |
CCL21, SCYA21, UNQ784/PRO1600: Small-inducible cytokine A21 precursor |
OPRM1 |
OPRM1, MOR1: Mu-type opioid receptor |
0.468 |
Evidence |
|
| CCL21 |
CCL21, SCYA21, UNQ784/PRO1600: Small-inducible cytokine A21 precursor |
DPP8 |
DPP8, DPRP1, MSTP097, MSTP135, MSTP141: Dipeptidyl peptidase 8 |
0.468 |
Evidence |
|
| CCL24 |
CCL24, MPIF2, SCYA24: Small-inducible cytokine A24 precursor |
OPRM1 |
OPRM1, MOR1: Mu-type opioid receptor |
0.468 |
Evidence |
|
| CCL24 |
CCL24, MPIF2, SCYA24: Small-inducible cytokine A24 precursor |
DPP8 |
DPP8, DPRP1, MSTP097, MSTP135, MSTP141: Dipeptidyl peptidase 8 |
0.468 |
Evidence |
|